EUVIMED · CrossrefZeitschrift
Exploration of Targeted Anti-tumor Therapy
ISSN 2692-3114 · Open Exploration Publishing
Neueste Artikel
Unmet needs beyond precision in gastrointestinal cancers
Macrophage-like phenotypes of tumor-immune hybrid cells in primary breast cancer
Targeting tumor transition windows
Predictive biomarkers for immunotherapy response in endometrial cancer: current insights and future directions
Reactive oxygen species (ROS) in cancer: from redox signaling and metabolic plasticity to therapeutic vulnerabilities
Oncologic outcome and safety profile of first-line enfortumab vedotin plus pembrolizumab vs. conventional chemotherapy in advanced urothelial cancer
ESR1 mutations in ER-positive breast cancer: from endocrine resistance to ctDNA-guided therapeutic interception
The evolution of chemotherapy in brain tumors: from historical milestones to precision medicine in glioblastoma
Triple-negative breast cancer: current understanding and future perspectives
Glioblastoma pathophysiology: roles of aging driven changes in STAT3 interactions with NF-κB dimer components in the modulation of the mitochondrial melatonergic pathway and night-time inflammation resolution
Application of explainable artificial intelligence integrating with electronic health record in oncology
Next-generation nanocarriers for precision antitumor therapy: from passive targeting to intelligent response
Bispecific antibodies in the treatment of epithelial ovarian, endometrial, and cervical cancer: an overview of current applications, challenges, and emerging opportunities
Engineered nanocarriers for targeted lung cancer therapy: mechanistic innovations and recent clinical progress
Metabolic plasticity drives specific mechanisms of chemotherapy and targeted therapy resistance in metastatic colorectal cancer
Dysbiosis and colorectal cancer: conducive factors, biological and molecular role, and therapeutic prospectives
Comparison of outcomes of neoadjuvant chemotherapy in BRCA1- versus BRCA2-associated breast and ovarian cancers
Osteosarcoma: current insights and advances
Role of exosomes in transforming growth factor-β-mediated cancer cell plasticity and drug resistance
Harnessing the power of tumor-draining lymph nodes: unveiling predictive biomarkers for immune checkpoint inhibitor
Neoantigen-based immunotherapy: advancing precision medicine in cancer and glioblastoma treatment through discovery and innovation
Cytokine-based immunotherapy for gastric cancer: targeting inflammation for tumor control
Modulation of anti-tumour immunity by XPO1 inhibitors
Nanoimmunotherapy: the smart trooper for cancer therapy
Strategies to overcome resistance to enfortumab vedotin and pembrolizumab for patients with urothelial carcinoma: harnessing present knowledge for future advances
State-of-the-art photodynamic therapy for malignant gliomas: innovations in photosensitizers and combined therapeutic approaches
Pancreatic cancer: failures and hopes—a review of new promising treatment approaches
Metabolic mechanisms of immunotherapy resistance
Shorter telomere length as a prognostic marker for survival and recurrence in breast cancer: a systematic review and meta-analysis
Nigerian medicinal plants with potential anticancer activity—a review
EUVIMED